Clinical Trial Update: An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating 2+1 versus 3+0 PCV13 vaccination schedules and their effect on nasopharyngeal pneumococc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: University of Liverpool | Conditions: 13-valent Pneumococcal Vaccine, Streptococcus Pneumoniae | Status: COMPLETED